Insurance can feel burdensome. Janssen can help you navigate the approval process.
When you enroll patients through Janssen CarePath:
- Janssen CarePath Care Coordinators will conduct a benefits investigation and help you navigate the approval process
- Patients will be able to enroll in Janssen-sponsored support programs
>90%
PA approval rate for provider offices that use Janssen CarePath1
Our Therapy Access Managers are here to provide education and assistance throughout the payer approval and patient access processes to help your patients access, start, and stay on their prescribed Janssen PAH therapy.
If you have questions, call a Janssen CarePath Care Coordinator
at 866-228-3546, Monday-Friday, 8 am to 8 pm ET.
UPTRAVI® Patient Enrollment Form
Print and fill out the UPTRAVI® Patient Enrollment Form to get your patients started with UPTRAVI® (selexipag). The Patient Enrollment Form is not optimized for mobile devices. Please print, sign, and fax to Janssen CarePath.
UPTRAVI® VA Patient Enrollment Form
Note: An alternate form is available for Veteran Affairs (VA) patients UPTRAVI® VA Patient Enrollment Form.
Guide to the UPTRAVI® Patient Enrollment Form
Download the Guide to the UPTRAVI® Patient Enrollment Form, which provides detailed instructions to help you fill out the form.
Prescribe UPTRAVI® Online Through iAssist
UPTRAVI® may now be prescribed through iAssist, a web-based platform that streamlines the prescription and enrollment process. Instead of faxing individual enrollment forms and insurance information, data can be entered in one place online to minimize incomplete forms and multiple submissions.
Janssen believes that cost, coverage, and uncertainty shouldn’t stand in the way of patients and their medications
Janssen CarePath Oral PAH Saving Program
Once you’ve decided to prescribe a Janssen PAH therapy, support for patients using commercial or private insurance to pay for medication is available. Janssen CarePath Oral PAH Savings Program can help eligible patients save on their out-of-pocket costs for their Janssen medication. Your eligible patients will pay $5 per prescription fill for UPTRAVI® (selexipag). Maximum program benefit per calendar year shall apply across all oral PAH therapies in the program. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change.
See program requirements at PAH.JanssenCarePathSavings.com
Once a decision has been made to prescribe a Janssen PAH medication, Janssen CarePath can provide information about other resources that may be able to help your patients with their out-of-pocket medication costs. Visit JanssenCarePath.com for more information on affordability programs that may be available.
Information about your patient’s insurance coverage, cost support options, and treatment support is given by service providers for Janssen CarePath. The information you get does not require you or your patient to use any Janssen product. Because the information we give you comes from outside sources, Janssen CarePath cannot promise the information will be complete. Janssen CarePath cost support is not for patients in the Johnson & Johnson Patient Assistance Foundation.
Janssen Patient Assistance Program
Patient assistance is available if your patient has commercial, employer-sponsored, or government coverage that does not fully meet their needs. Your patient may be eligible to receive their Janssen medication free of charge for up to one year if they meet the eligibility and income requirements for the Janssen Patient Assistance Program. See terms and conditions at PatientAssistanceInfoPH.com.
Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization. JJPAF gives eligible patients free prescription medicines donated by Johnson & Johnson companies. Patients may be eligible if they don’t have insurance.
Do you have patients who may need help? They can see if they are eligible and get an application at JJPAF.org or call 833-919-3510 (toll free) / 308-920-4358 (direct dial), Monday through Friday, 8:00 AM to 8:00 PM ET.
We offer patients one-on-one educational support that may help them to stay on their prescribed therapy longer2,3*
Once a decision has been made to prescribe a Janssen PAH medication, PAH Companion withMe† is a suite of patient support resources customized for your patients’ specific questions, needs, and interests. One-on-one educational conversations with a dedicated PAH Companion—coupled with access to current PAH tools and resources—help your patients take a more active role in their care. Learn more at PAHcompanion.com
DID YOU KNOW?
Over 10,000 patients have engaged with a dedicated PAH Companion, and those who do are more likely to stay on therapy longer. Ninety-four percent of patients who have enrolled and engaged with a dedicated PAH Companion would recommend the program to others.4,5
A dedicated PAH Companion is ready to answer your patients’ questions and help them navigate their treatment experience. Patients who have enrolled can connect with their personal PAH Companion by calling 866-300-1818, Monday–Friday, 8:00 AM to 9:00 PM ET.
PAH Companion withMe is limited to education for patients about their PAH therapy, its administration, and/or their disease, and is not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, or provide case management services.
FOR YOUR PATIENTS PRESCRIBED UPTRAVI®
Janssen-Sponsored Specialty Pharmacy (SP) UPTRAVI® Titration Education Program
After you, as the treating healthcare professional (HCP), have made the decision to prescribe UPTRAVI®, you may choose for your patient to receive nurse-supported titration education as they start therapy.
For patients to receive this service, you must check the box in section 4 (choose virtual or in-home visits) of the enrollment and prescription form to opt in to the Janssen-Sponsored SP UPTRAVI® Titration Education Program.
Within 48 hours of your patient’s receipt of their first UPTRAVI® shipment, an SP Nurse can have an interaction with your patient.
80%
of new patients utilize the program6
PROGRAM FEATURES
During these visits with your patient, the nurse can:
Educate
the patient on what to expect as they start therapy with UPTRAVI®
Ensure
the patient’s understanding of reaching their personal dose
Educate
the patient to help address potential misconceptions about UPTRAVI® dosing
Provide
the patient and/or their caregiver with recommendations on when to call their HCP
The program is delivered to patients virtually (by video or phone) or in-home, depending on the patient or provider preference captured on the enrollment and prescription form or communicated by patient or provider.
The program will take place during a series of interactions aligned with the UPTRAVI® dose titration schedule. The program will conclude after 5 interactions. If a patient requires additional titration education beyond 5 interactions, the patient may receive a limited number of additional interactions.
The information provided is educational in nature and not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe.
